Transient hyper-17-OHPnemia unrelated to cross-reactions with residual fetal adrenal cortex products

Hormone Research

Volumn 61, Issue 5, 2004, Pages 242-245

  Mizuno, Haruo ^a   Ohro, Yoichiro ^a   Sugiyama, Yukari ^a   Ito, Tetsuya ^a   Hasegawa, Tomonobu ^b   Homma, Keiko ^b   Ueshiba, Hajime ^c   Ono, Makoto ^d   Togari, Hajime ^a  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^b KEIO UNIVERSITY   (Japan)

^c TOHO UNIVERSITY   (Japan)

^d TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

21 Hydroxylase; Gas chromatography mass spectrometry; High performance liquid chromatography radioimmunoassay; Hyper 17 hydroxyprogesteronemia; Transient hyper 17 OHPnemia

Indexed keywords

HYDROXYPROGESTERONE; PREGNANETRIOLONE; SEX HORMONE; STEROID 21 MONOOXYGENASE; UNCLASSIFIED DRUG;

ADRENAL CORTEX; ARTICLE; CASE REPORT; CROSS REACTION; GENETIC ANALYSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HORMONE BLOOD LEVEL; HORMONE METABOLISM; HUMAN; INFANT; LABORATORY TEST; MALE; METABOLIC DISORDER; PATHOGENESIS; PREMATURITY; PRIORITY JOURNAL; RADIOIMMUNOASSAY; TRANSIENT HYPERHYDROXYPROGESTERONEMIA;

17-ALPHA-HYDROXYPROGESTERONE; ADRENAL CORTEX; ADRENOCORTICOTROPIC HORMONE; AGING; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CROSS REACTIONS; FETUS; HUMANS; INFANT, NEWBORN; MALE; POLYMERASE CHAIN REACTION; PREGNANETRIOL; RADIOIMMUNOASSAY; STEROID 21-HYDROXYLASE; TIME FACTORS;

EID: 1842851860     PISSN: 03010163     EISSN: None     Source Type: Journal    
DOI: 10.1159/000076961     Document Type: Article

References (12)

1. Hughes IA, Winter JSD: The application of serum 17-OH-progesterone radioimmunoassay to the diagnosis management of congenital adrenal hyperplasia. J Pediatr 1976;88:766-773.
2. 450 17α-hydroxylase/17,20-lyase, and 3β-hydroxysteroid dehydrogenase isomerase steroidogenic enzymes in human and rhesus monkey fetal adrenal glands: Reappraisal of functional zonation. J Clin Endocrinol Metab 1993;77:1184-1189.
3. Hingre RV, Gross SJ, Hingre KS, Mayes DM, Richman RA: Adrenal steroidogenesis in very low birth weight preterm infants. J Clin Endocrinol Metab 1994;78:266-270.
4. Ueshiba H, Segawa M, Hayashi T, Miyachi Y, Irie M: Serum profile of steroid hormone in patients with Cushing's syndrome determined by new HPLC/RIA method. Clin Chem 1991;37:1329-1333.
5. Caulfield MP, Lynn T, Gottschalk ME, Jones KL, Taylor NF, Malunowicz EM, Shackleton CH, Reitz RE, Fisher DA: The diagnosis of congenital adrenal hyperplasia in newborn by gas chromatography/mass spectrometry analysis of random urine specimens. J Clin Endocrinol Metab 2002;87:3682-3690.
6. Homma K, Hasegawa T, Masumoto M, Takeshita E, Watanabe K, Chiba H, Kurosawa T, Takahashi T, Matsuo N: Reference values for urinary steroids in newborn infants: Gas chromatography/mass spectrometry in selected ion monitoring. Endocr J 2003;50:783-792.
7. Koyama S, Toyoura T, Saisyo S, Shimozawa K, Yata J: Genetic analysis of Japanese patients with 21-hydroxylase deficiency: Identification of a patient with a new mutation of a homozygous deletion of adenine at codon 246 and patients without demonstrable mutations within the structural gene for CYP21. J Clin Endocrinol Metab 2002;87:2668-2679.
8. New MI, Lorenzen F, Lerner AJ, Kohn B, Oberfield SE, Pollack MS, Dupont B, Stoner E, Levy DJ, Pang S, Levine LS: Genotyping steroid 21-hydroxylase deficiency: Hormonal reference data. J Clin Endocrinol Metab 1983;57:320-326.
9. Hughes IA, Riad-Fahmy D, Griffiths, K: 17-OH-progesterone concentration in newborn infants. Arch Dis Child 1979;54:347-349.
10. Cacciari E, Balsamo A, Cassio A, Piazzi S, Bernardi F, Salardi S, Cicognani A, Pirazzoli P, Zappulla F, Capelli M, Paolini M: Neonatal screening for congenital adrenal hyperplasia. Arch Dis Child 1983;58:803-806.
11. Berry J, Betts P, Wood PJ: The interpretation of blood spot 17α-hydroxyprogesterone levels in term and pre-term neonates. Ann Clin Biochem 1986;23:546-551.
12. Ohkubo S, Shimozawa K, Matsumoto M, Kitagawa T: Analysis of blood spot 17α-hydroxyprogesterone concentration in premature infants-proposal for cut-off limits in screening for congenital adrenal hyperplasia. Acta Pediatr Jpn 1992;34:126-133.